Biomedical engineering (BME) strives to develop new tools to improve human health. At Cornell’s Meinig School , our goal is to understand the human body as an integrated system through quantitative engineering analysis, and then to develop better therapies, devices, and diagnostics. Our focus is to predict how changes at the molecular level relate to the cellular, tissue/organ, and ultimately to whole body level responses. Cornell's M.Eng. Degree in BME focuses on professional practice and engineering design. Our five main areas are: instrumentation & diagnostics, biomedical mechanics,...
A multi-campus study of lymphoma shows that certain cell mutations in tumors can cause the cancer to be resistant to chemotherapy, with biophysical forces such as fluid flow playing a key role.
Scientists represented Cornell at the annual USA Science and Engineering Festival in Washington, D.C., April 7-8.
The Meinig School of Biomedical Engineering proudly congratulates Ph.D. students Jason Chang (Andarawis-Puri Lab), Monideepa Chatterjee (Andarawis-Puri Lab), Carolyn Chlebek ( van der Meulen Lab ), Joseph Long ( Lammerding Lab ), Brittany Schutrum ( Fischbach Lab ), Regan Stephenson ( Singh Lab ), Tibra Wheeler ( Singh Lab ), and Matt Whitman ( Fischbach Lab ), as well as one undergraduate senior, Joseph Kim ( Cosgrove Lab ), who each recently won a 2018 National Science Foundation (NSF) Graduate Research Fellowship (GRFP). The NSF GRFP offers 3 years of stipend support during a 5-year...
Orthofit, the newest member of Rev: Ithaca Startup Works, is refining the prototype of its signature product – a “smart” glove.
Cornell will hold the first Annual Cancer Research Symposium to showcase diverse and groundbreaking cancer research on campus, and to better integrate investigators from the Ithaca campus and Weill Cornell Medicine.
Campus leaders, students and family members attended a memorial service for the late Peter Meinig, who chaired the Cornell University Board of Trustees 2002-11.
The labs of Matt DeLisa and Dave Putnam has teamed with a group from Harvard to work on a vaccine delivery system based on DeLisa's versatile outer membrane vesicles.
A new initiative aims to increase participation rates and enhance the success of under-represented ethnic minorities and students who are deaf or hard of hearing in biological and biomedical graduate fields at Cornell.
Cornell delegates to the Clinton Global Initiative University presented their commitments to action at a pitch competition Jan. 31.